Purpose To evaluate if nurses after receiving training in clinical pharmacology can improve the quality of the drug therapy in elderly hospitalized patients. Methods Nurses were given a 1-day training in clinical pharmacology to identify drug-related problems (DRPs). All patients admitted to the ward aged 65 or more were studied. Patients at the same ward before the intervention were considered as control group. Outcome variables were re-hospitalized 3 months from discharge, drug-related readmissions, the proportion of inappropriate drug use (IDU), and DRPs found by the nurses. Results Of 460 patients (250 intervention group and 210 in the control group) 38 and 36%, respectively, had at least one re-admission to hospital (p=0.86) and 24% of the patients died. Eighteen and 17% (43/37), respectively, used one or more inappropriate drug (p 0.90). The nurses found 86 clinically significant DRPs not detected by the usual care. A substantial part of the DRPs detected by the nurses were revealed with assistance of Symptoms Assessment Form (SYM). There were no statistical difference in the number of drug-related re-admissions between the groups, 14/16, respectively, (p=0.40). Conclusions Nurses are able to detect a high proportion of clinically relevant DRPs not detected by the usual care and thereby increase the quality of the drug treatment in elderly hospitalized patients. Our study showed no effect on rehospitalization or IDU. By using a SYM nurses can find DRPs that computer-based decision support systems miss.
Introduction
Whenever a patient is treated with one drug or more, drugrelated problems (DRPs) may occur. It may be a trivial DRP, not affecting the health outcome of the patient, or it could turn into a problem of clinical relevance, leading to hospitalization and/or death. People aged 65 and over have a higher prevalence of DRPs [1] [2] [3] . This may be due to a combination of factors such as several illnesses leading to a need for more drugs. Polypharmacy increases the risk of drug-drug interactions (DDIs) and other DRPs [4, 5] . Increased disability and dependency on assistance may result in difficulty adhering to the drug regime. Changes in age-related pharmacokinetics and pharmacodynamics may have an effect. The main reason for age-related effects on the drug action is that the drug elimination is less efficient in elderly people, so that drugs often produce greater and more longlasting effects. The elimination rate is impaired as a result of age-related changes in the renal structure. Glomerular filtration rate (GFR) starts to decline from the age of 20 and will have fallen by about 50% at 75 years of age [6] . A considerable number of elderly patients with decreased renal function are being prescribed drugs that should be dose adjusted, used with caution, or avoided [7] [8] [9] .
Many elderly people use potentially inappropriate medication [3, 8, [10] [11] [12] [13] . Inappropriate drugs in older people are drugs with no clear evidence-based indication. Drugs carry a substantially higher risk of adverse sideeffects in the elderly compared to young people [14, 15] .
A recently published study states that prescription of inappropriate medication to elderly people is highly prevalent, ranging from 12 to 40% in community-dwelling elderly and nursing home residents, respectively [11] . The quality of the drug therapy was evaluated in a study among elderly nursing home residents in Sweden, and the result showed that over 70% of the residents used one or more inappropriate drugs or drug combinations [13] . Other Swedish population-based studies among people 75 years and older have shown that inappropriate drug use (IDU) is common, with a prevalence of 16.5-19% [8, 12] . IDU is associated with adverse drug events (ADEs) and is an important reason for unplanned admittance to hospital of elderly people [8, [16] [17] [18] [19] . The proportion of drug-related hospital admissions has been shown to be up to 6%, with a substantially higher proportion among elderly patients [2, 17, 18, [20] [21] [22] . This problem is well known and has been addressed in many studies. However, there is little agreement on how to prevent the need for drug-related hospital admission of elderly people. Regular reviewing of the medication treatment seems to be rational. Medication reviews have been made by pharmacists and by clinical pharmacologists [23] [24] [25] [26] , but the effects on the quality of the drug therapy or on the number of hospital admissions are contradictory.
Studies have shown that nurse-led medication reviews with subsequent intervention can reduce re-admissions to hospital of patients with heart failure [27, 28] , and a homebased intervention assessed by a pharmacist and a nurse showed a 25% reduction in unplanned re-admissions to hospital [29, 30] . A recently published study has shown that after training in clinical pharmacology, nurses are able to identify DRPs not detected during the usual care in hospitalized patients [31] . There are, to our knowledge, no randomized studies aiming at reducing drug-related readmission of elderly patients that evaluate the nurse's role in identifying potential DRPs.
Aim
The aim of this study was to evaluate if nurses, after specific training in clinical pharmacology, can improve the quality of the drug therapy in elderly hospitalized patients.
Materials and methods

Study site
This intervention study was carried out in a 22-bed ward of the Division of Internal Medicine in a large hospital in Stockholm. The ward admits approximately 1,750 patients a year, and 36 nurses serve on a regular basis in three shifts.
The patients
All patients aged 65 or more treated over a 3-month period (October-December 2006) at the ward represent the intervention group and were eligible for the study. Exclusion criterion was protected identity. Patients treated over a 3-month period (July-September 2006) at the same ward before the intervention were considered as control group.
The intervention
All nurses serving at the ward on a regular basis were offered a 1-day training in clinical pharmacology, described elsewhere [31] . Ninety percent (n=32) of the nurses participated. The purpose of the training was to give the nurses the knowledge and tools to identify patients at high risk of drug-related problems (DRPs) and to find the DRPs. Tools to find possible DRPs were a symptom assessment form (SYM) containing questions on symptoms caused by common drugs, access to a web application to estimate renal function by calculating creatinine clearance, and access to a special web application, the Janus Web Application (JWA) [32] , to determine possible drug-drug interactions (DDIs). Two nurses were chosen to function as instructors for the other nurses. The instructors were each allowed 8 h/week for identifying possible DRPs in the patients admitted to the ward studied.
Outcome variables
Main outcome was re-hospitalization within 3 months from discharge. Secondary outcome was the proportion of inappropriate drug use (IDU) at discharge, the proportion of drug-related re-admissions, and the frequency of DRPs found by the nurses. Re-admission and death were examined for all studied patients within 3 months after discharge. Hospital admission data were provided by Hospital Episode Statistics. Determination of potential IDU is based on four quality indicators developed by The Swedish National Board of Health and Welfare [33] : use of at least one anticholinergic drug, use of at least one long-acting benzodiazepine (e.g., diazepam, flunitrazepam, nitrazepam), concurrent use of three or more psychotropic drugs (i.e., neuroleptics, anxiolytics, hypnotics/sedatives, antidepressants), and at least one combination of drugs that may lead to a potentially serious DDI type D. IDU is defined as exposure to at least one of the four quality indicators. These quality indicators are in accordance with the Beers criteria [14, 33] . Serious DDIs are classified according to the JWA for detecting DDIs [32] . In brief, DDIs are divided into four levels of clinical relevance, types A, B, C, and D [32] . We have focused on potentially serious DDIs type D, "should be avoided."
Drug-related re-admission Drug-related morbidity is defined as admission to hospital for treatment of drug-related adverse effects according to the International Classification of Diseases 9th version (ICD-9) (WHO 1978). Six diagnostic codes were used: X579 (accidental exposure to other and unspecified factors), X6199 (intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonian, or psychotropic drugs, not elsewhere classified), X4403 (accidental poisoning by and exposure to other and unspecified drugs, medicaments, and biological substances), Y579 (complications of drug or medicament, unspecified) F130 (mental and behavioral disorders due to use of sedatives or hypnotics), and X403 (accidental poisoning by and exposure to non-opioid analgesics, antipyretics, and antirheumatics). Drug-related re-admission was also estimated by a reviewer who scrutinized the patient's medical record. Drug-related re-admission was defined if the patient's medical record included any of these diagnostic codes at re-admission or if the reviewer who scrutinized the medical records judged the re-admission to be drug-related. Drug-related causes for re-admission were assessed as "major cause for the re-admission" or "contributing cause for the re-admission," and as to whether or not the assessment was "certain" or "uncertain."
Statistics
Power calculation was made for the second outcome variable, IDU. A sample of 396 patients (198 per group) was needed in order to detect with 80% power a difference of 40% (from 30% to 18%) in the number of patients with one or more inappropriate drug or drug combination. A P value of <0.05 was considered significant.
Statistical Package for the Social Sciences (SPSS) version 16.0 was used for the analyses.
Statistical significance was assessed with an alpha level of 0.05. Basic chi-squared and t-tests were performed to examine the difference between the intervention and control groups.
Ethics approval
Approval was obtained from the Research Ethics Committee, Karolinska Institutet, Stockholm, Sweden.
Results
The nurses found 86 clinically significant DRPs not detected by the usual care. There was no statistically significant difference in re-admission in the intervention or control group. There was also no statistically significant difference in the number of patients using inappropriate drugs. Table 1 shows the characteristics of the 460 patients enrolled in the study-250 in the intervention group and 210 in the control group. There were 56% women in the intervention group and 53% in the control group. The mean age of the patients was 80.3 years. Drugs were used on a regular or as-needed basis by 94% (n=433) of the study population. The mean number of different drugs per person used on a regular or as-needed basis at admission was 6.9 and 6.2, respectively, in the two groups (range 0-20). More than half of the patients had some degree of renal insufficiency, and the proportion of patients having serum creatinine levels within the normal range but reduced estimated GFR ("hidden renal insufficiency") was 82 with a Seven in the intervention group and five in the control group could not have their renal function estimated due to lack of creatinine value b Ninety-three in the intervention group and 90 in the control group could not have their renal function estimated due to lack of creatinine value or weight data a substantially higher proportion among the women than men, 56/144 (39%) and 26/133 (20%), respectively, in thos in which creatinine clearance could be estimated. There were no apparent differences in the demographic profiles of the intervention and the control group.
Patient characteristics
Re-admission to hospital
There was no statistically significant difference in readmission between the groups (Table 2) . During follow-up (3 months after discharge), 37% (n=170) of the 460 patients had had at least one re-admission to hospital, 38% (n=94) and 36% (n=76), respectively, in the two groups (P=0.86). During the 3-month follow up, 24% of the patients died. The combined rate of re-admission and death was 59% (n=147) in the intervention group, and 54% (n=115) in the control group (P=0.64).
The prevalence of inappropriate drug use (IDU) at discharge Table 2 shows the distribution of IDU. The overall prevalence of patients using one or more inappropriate drugs was 17%. There were 43 patients using one or more inappropriate drugs in the intervention group and 37 patients in the control group, i.e., no significant difference between the groups (P=0.90). Some of the patients used more than one inappropriate drug. The overall prevalence of IDU was 102 (60 intervention/42 control). Anticholinergics accounted for 40% (n=24/17), long-acting benzodiazepines for 17% (n=9/8), three or more psychotropic drugs for 32% (n=22/11), and potentially serious drugdrug interactions (grade D) counted for 11% (n=5/6). The most frequently prescribed anticholinergic drugs were urological spasmolytics (G04BD) in the intervention group, and opiates and opioids in combination with spasmolytics (N02AG) in the control group. The most common potentially serious drug-drug interaction was a combination of potassium supplement and potassiumsparing diuretic.
DRPs detected by the nurses
Of the 250 patients in the intervention group, medication reviews were documented for a total of 73 patients. The rest, 177 patients, received the usual care, but by nurses who had had the special pharmacological training and who were encouraged to be alert for any signs of DRPs. The nurses found 86 DRPs in 53 patients not detected by the usual care ( Table 3) . The nurses revealed patients at risk of adverse drug reactions (ADRs) due to a combination of decreased renal function and too high a dosage of drugs, or inappropriate drugs due to the patient's age. The nurses also found potential DDIs (types C and D), such as risk of intestinal bleeding due to a combination of antitrombotic agents and NSAIDs; risk of nil effect of antibiotics due to a DDI between ciprofloxacin and iron compounds or calcium compounds; and risk of hyperkalemia due to a DDI between potassium chloride and potassium-sparing diuretics. The DDIs in the current study had not caused any symptoms for the patient. Furthermore, 23 (ADRs) according to the WHO definition [34] were detected by the nurses. The Table 4 . A substantial number of the DRPs were revealed with assistance of SYM.
Assessment of the drug-related causes for re-admission
There was no difference in the number of drug-related re-admissions between the groups. Of the 170 patients who were re-admitted to hospital, 105 records were available for analysis of possible drug-related causes for the re-admission. Of these re-admissions, 28% were judged to be drug-related (14 patients in the intervention group and 16 in the control group, with no statistical difference, P=0.40).
Discussion
This study is the largest of its kind of nurse-led intervention aiming at reducing DRPs. The study shows that a 1-day training of nurses in clinical pharmacology contributes to their finding patients at risk of getting a DRP, enabling the nurses to prevent an ADR. The nurses in this study found 86 clinically significant DRPs not detected by the usual care. Although there was no decrease in re-admissions after the intervention, we can show that many DRPs not detected by the usual care could easily be detected by nurses. This nurse-led intervention is new and has been tested in a previous study [31] . The new feature of this method is the structure whereby the nurse has a leading role. Three measures are undertaken: completion of an SYM containing questions on symptoms caused by common drugs, measurement of the patient's actual renal function, and determination of possible DDIs.
Other studies
The literature on nurse-led intervention aiming at reducing DRPs and IDU is limited. A meta-analysis from 2006 shows no evidence for the effectiveness of nurse-led intervention aiming at reducing re-admission to hospital and drug-related morbidity [18] . In contrast, Blue et al. were able to demonstrate that nurses could improve the outcome of patients admitted to hospital with heart failure. Compared with the usual care, the patients in the intervention group had fewer re-admissions and spent fewer days in hospital because of heart failure [27] . A Dutch study also indicated that a combined intervention by a clinician and a cardiovascular nurse substantially reduced hospitalization for worsening heart failure and/or all-cause mortality [28] . Pharmacist-led interventions aiming at reducing DRPs are quite common but without consistent evidence of their value at reducing re-admissions. Recently two metaanalyses have been published showing that pharmacists failed to reduce hospital admissions [18, 24] . However, a slight reduction in the number of prescribed drugs could be showed. The authors even showed a higher rate of hospital admissions after intervention by a pharmacist, which shows the complexity of the problem [24] . However, intervention studies made by nurses and pharmacists or nurses and clinical pharmacologists working together in multi-disciplinary teams have shown some benefits [25, 26, 30] . In summary, previous studies of interventions aiming at reducing DRPs are inconsistent. The complexity of the problem of drug-related hospital admissions requires a new approach. In accordance with other studies, our study describes the proportion of inappropriate drugs used in the treatment of elderly people as high [3, 8, 10, 12, 13, 26] ; 17% of our study population took one or more inappropriate drugs or drug combinations. However, some drugs routinely considered to be inappropriate may be appropriate for the individual patient within the clinical context [35] . There may be a risk of overestimating the use of inappropriate drugs when using computer-based decision support systems (CDSS). A medication review must always include a clinical judgement by a physician with knowledge of the patient's present health and social status. A substantial part of the DRPs found by the nurses were of a kind that could not have been detected with a CDSS. To be able to find these DRPs, a symptom assessment made by a nurse was needed.
Renal function
A major portion of the DRPs found by the nurses were patients at risk of getting ADRs due to impaired renal function. To avoid IDU in the elderly, an accurate assessment of the renal function is extremely important [36, 37] . Although serum creatinine is the most common laboratory test used for identifying renal impairment, it fails to detect such in many patients, particularly elderly women [36] [37] [38] [39] . In our study, 54% of the patients had some degree of renal insufficiency, and the prevalence of "hidden renal insufficiency" (serum creatinine levels within the normal range but reduced estimated GFR) was high, especially among the women (Table 1) . Our findings that women are more likely to have a "hidden renal insufficiency" is in agreement with findings in other studies [37, 38] . In our study, 39% of the women and 20% of the men (of 144 women and 133 men in whom creatinine clearance could be estimated) suffered from "hidden renal insufficiency," which increases the risk of getting too high drug doses. Medication safety can potentially be improved through a more comprehensive assessment of the renal function. Calculation of an estimated creatinine clearance is easily and quickly done and could be part of a routine assessment by a nurse to identify patients at risk of having DRPs [37] . Other routines are already implemented to identify at-risk patients, e.g., calculation of body mass index (BMI) to identify patients at risk of malnutrition, and calculation of risk of pressure ulcers by using the modified Norton scale.
Interpretations
One possible reason for the results may be that the outcome re-hospitalization, and the prevalence of patients with IDU, may not relate to the intervention delivered. The mortality within 3 months in this study was 24%, which indicates how frail these patients are. The goal of caring for this vulnerable population must be to optimize their quality of life. Many of the DRPs found were causing the patients ADRs that are known to severely affect the patients' quality of life, such as dry mouth, constipation, and nausea [40] [41] [42] [43] [44] .
However, previous studies have shown that even a short instruction and training of nurses can result in nurses detecting DRPs and reporting ADRs [31, 45, 46] . Drug treatment of elderly people presents a complex problem that requires an interdisciplinary approach. Nurses often are the first to notify the physician of the need for a medication or medication changes. Nurses work near the patient and have a comprehensive view of him/her and are thus in a perfect position to identify and alert for possible DRPs.
Limitations and strengths
This study required no consent by the patients, so all patients 65 and older admitted to the ward during the study period were included, and there was thus no selection bias. The intervention and the control groups were essentially equal in characteristics. None of the patients was withdrawn or lost to follow-up. Hospital admission data were provided by data from the Hospital Episode Statistics and are thus unlikely to have introduced bias. The educational intervention and the method for DRP detection have been evaluated in another study, showing them to be feasible and well accepted by nurses [31] . The ward has no history of seasonal variation. Educational interventions other than ours or changes among the personnel or in the ward were outside our control, but there was no time gap between the control group (July-September 2006) and the intervention group (October-December 2006).
The 3-month cut-off point was selected to capture the majority of re-admitted patients. In previous studies we established that almost 40% of all patients admitted to an internal medicine ward are re-admitted within 6 months after discharge, and 17% of the patients died [26, 31] .
A reasonable reduction in re-admission would have been 5 percentage units, i.e., half of the drug-related hospitaladmissions, since 10-30% of the hospitalization of the elderly is drug-related [1] [2] [3] . To test this difference statistically with an alpha of 0.05 and a beta of 80%, the study would have required at least 9,336 patients in each group. Such a study was not possible for us to do in this clinical setting. Although we had no power for the primary outcome, we wanted the outcome to be re-admission because of its indisputable value as indicator of health.
Since it was impossible for us to obtain power for our primary outcome, we chose to calculate power for our secondary outcome, IDU at discharge. IDU is a more subtle, flexible but disputable indicator for health. Some medications routinely considered to be inappropriate may be appropriate for the individual patient. In the current study, 17% of the patients were exposed to a potential IDU, which is in agreement with other Swedish population studies [12] . In our power calculation, we thought the prevalence would be higher because the patients in our study were admitted to hospital and thus more vulnerable and more exposed to poly-pharmacy [11] .
Conclusions
Our study shows that nurses are able to detect a high proportion of clinically relevant DRPs not detected by the usual care, thereby increasing the quality of the drug treatment in elderly hospitalized patients. Our study showed no effect on re-hospitalization or IDU. By using a symptoms assessment form, nurses can find DRPs that computer-based decision support systems (CDSS) and usual care miss.
